{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:52:26Z","timestamp":1778233946739,"version":"3.51.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The evaluation of microvascular alterations might provide clinically useful information for patients with an increased cardiovascular (CV) risk, such as those with rheumatoid arthritis (RA), being the small artery remodeling the earliest form of target organ damage in primary CV diseases, such as arterial hypertension. The evaluation of retinal arterioles is a non-invasive technique aimed to identify an early microvascular damage, represented by the increase of the wall-to-lumen ratio (WLR) index. Abatacept (ABA), a T-cell co-stimulator blocker, is used to treat RA. A CV protective action was hypothesized for its peculiar mechanism of action in the modulation of T-cells, potentially involved in the pathogenesis of CV comorbidity. The study aimed to non-invasively investigate morphological characteristics of retinal arterioles in a cohort of RA patients treated with ABA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Seventeen RA patients [median (25th-75thpercentile) age\u2009=\u200958 (48\u201364) years, baseline 28-joint Disease Activity Score DAS28-C-reactive protein (DAS28-CRP)\u2009=\u20094.4 (3.9\u20134.6), body mass index (BMI)\u2009=\u200924.2 (23.4\u201326) kg\/m<jats:sup>2<\/jats:sup>, rheumatoid factor positive:52.9%, anti-citrullinated peptide autoantibodies positive:76.5%] without known CV risk factors (arterial hypertension, diabetes, hypercholesterolemia, previous CV events, smoking) were evaluated by the adaptive optics imaging system of retinal arterioles before and every 6\u2009months of therapy with ABA (T0, T6 and T12). Office blood pressure evaluation, 24-h ambulatory blood pressure monitoring and tissue-doppler echocardiography were also performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A progressive significant reduction of the WLR of retinal arterioles was observed [T0\u2009=\u20090.28 (0.25\u20130.30), T6\u2009=\u20090.27 (0.24\u20130.31), T12\u2009=\u20090.23 (0.23\u20130.26); p T0 vs. T6\u2009=\u20090.414; p T6 vs. T12\u2009=\u20090.02; p T0 vs. T12\u2009=\u20090.009], without significant variations in other parameters. The T0-T12 reduction of WLR was correlated with that of DAS28-CRP (r:0.789; <jats:italic>p<\/jats:italic> =\u20090.005). Moreover, a significant reduction of diastolic office blood pressure and a trend for reduction of daily pressure measured by ambulatory monitoring were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In a cohort of RA patients without known CV risk factors, a reduction of retinal microvascular alterations was demonstrated after treatment for 12\u2009months with ABA, in parallel with the reduction of disease activity. These results might suggest the possibility of microvascular abnormalities regression induced by the immune system modulation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1247024","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:16:45Z","timestamp":1707884205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade"],"prefix":"10.3389","volume":"11","author":[{"given":"Silvia","family":"Piantoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Regola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Caproli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Trovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Agabiti","family":"Rosei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"De Ciuceis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lorenza","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Rizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Air\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE investigation","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1161\/01.CIR.0000131450.66017.B3","article-title":"CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients","volume":"109","author":"Gerli","year":"2004","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/art.1780400615","article-title":"Expansion of unusual CD4+ T cells in severe rheumatoid arthritis","volume":"40","author":"Martens","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham heart study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40292-015-0079-2","article-title":"How to identify hypertensive patients at high cardiovascular risk? The role of echocardiography","volume":"22","author":"Cuspidi","year":"2015","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/00004872-200105000-00013","article-title":"Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension","volume":"19","author":"Park","year":"2001","journal-title":"J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/eurheartj\/eht023","article-title":"The eye and the heart","volume":"34","author":"Flammer","year":"2013","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/HJH.0b013e32832401ea","article-title":"Altered structure of small cerebral arteries in patients with essential hypertension","volume":"27","author":"Rizzoni","year":"2009","journal-title":"J Hypertens"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ajh\/hpx211","article-title":"New methods to study the microcirculation","volume":"31","author":"Rizzoni","year":"2018","journal-title":"Am J Hypertens"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.9.6.7","article-title":"New Frontiers in noninvasive analysis of Retinal Wall-to-lumen ratio by retinal Vessel Wall analysis","volume":"9","author":"Streese","year":"2020","journal-title":"Trans Vis Sci Tech"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/HJH.0b013e328352f81d","article-title":"Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry","volume":"30","author":"Rizzoni","year":"2012","journal-title":"J Hypertens"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"12283","DOI":"10.1038\/srep12283","article-title":"Effects of age and blood pressure on the retinal arterial wall, analyzed using adaptive optics scanning laser ophthalmoscopy","volume":"5","author":"Arichika","year":"2015","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/HYPERTENSIONAHA.107.090779","article-title":"Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event","volume":"50","author":"Harazny","year":"2007","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1167\/iovs.08-3266","article-title":"Wall-to-lumen ratio of retinal arterioles and arteriole-to-Venule ratio of retinal vessels in patients with cerebrovascular damage","volume":"50","author":"Baleanu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1177\/11206721211035626","article-title":"OCT retinal angiography features in patients with rheumatoid arthritis: a pilot study","volume":"32","author":"Iacono","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12417","article-title":"Retinal vessel morphology in rheumatoid arthritis: association with systemic inflammation, subclinical atherosclerosis, and cardiovascular risk","volume":"24","author":"Anyfanti","year":"2017","journal-title":"Microcirculation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3906\/sag-1806-1","article-title":"Abnormal retinal microvasculature found in active rheumatoid arthritis:a different perspective of microvascular health","volume":"49","author":"Babao\u011flu","year":"2019","journal-title":"Turk J Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmed.2012.10.013","article-title":"Targeting CD4+CD28\u2212 T cells by blocking CD28 co-stimulation","volume":"19","author":"Air\u00f2","year":"2013","journal-title":"Trends Mol Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"70","author":"Felson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of cardiology guidelines for the management of arterial hypertension","volume":"21","year":"2003","journal-title":"J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00004872-200305000-00001","article-title":"European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement","volume":"21","author":"O\u2019Brien","year":"2003","journal-title":"J Hypertens"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.HYP.27.5.1046","article-title":"Cardiac and vascular structural changes: prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno study","volume":"27","author":"Muiesan","year":"1996","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.111.00006","article-title":"Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients","volume":"61","author":"Muiesan","year":"2013","journal-title":"Hypertension"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/JIR.S156822","article-title":"Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis","volume":"11","author":"Benucci","year":"2018","journal-title":"JIR"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/BTT.S52003","article-title":"Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis","volume":"7","author":"Mathieu","year":"2013","journal-title":"BTT"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/annrheumdis-2014-206411","article-title":"The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease","volume":"75","author":"Myasoedova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"ard-2022-223356","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","author":"Smolen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cvr\/cvs330","article-title":"CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(\u2212\/\u2212) mice","volume":"97","author":"Ma","year":"2013","journal-title":"Cardiovasc Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2017.00195\/full","article-title":"Expansions of cytotoxic CD4+CD28\u2212 T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection","author":"Broadley","year":"2017","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00380-013-0462-7","article-title":"Effect of the Kv1.3 voltage-gated potassium channel blocker PAP-1 on the initiation and progress of atherosclerosis in a rat model","volume":"30","author":"Wu","year":"2015","journal-title":"Heart Vessel"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3899\/jrheum.170926","article-title":"Cardiovascular (CV) risk after initiation of Abatacept versus TNF inhibitors in rheumatoid arthritis patients with and without baseline CV disease","volume":"45","author":"Jin","year":"2018","journal-title":"J Rheumatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e007393","DOI":"10.1161\/JAHA.117.007393","article-title":"Comparative cardiovascular risk of Abatacept and tumor necrosis factor inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus: a multidatabase cohort study","volume":"7","author":"Kang","year":"2018","journal-title":"JAHA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"14680","DOI":"10.1038\/ncomms14680","article-title":"T cell costimulation blockade blunts pressure overload-induced heart failure","volume":"8","author":"Kallikourdis","year":"2017","journal-title":"Nat Commun"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1247024\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:16:48Z","timestamp":1707884208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1247024\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":39,"alternative-id":["10.3389\/fmed.2024.1247024"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1247024","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"article-number":"1247024"}}